BeOne Medicines Ltd.
ONC
$308.63
-$5.04-1.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 94.32M | 1.27M | -139.70M | -150.92M | -120.41M |
| Total Depreciation and Amortization | 29.87M | 31.63M | 167.03M | -46.90M | 23.75M |
| Total Amortization of Deferred Charges | 5.75M | 1.17M | 4.73M | -2.31M | 1.18M |
| Total Other Non-Cash Items | 128.31M | 88.04M | 236.71M | 75.61M | 113.30M |
| Change in Net Operating Assets | 5.35M | -78.03M | -157.17M | 263.35M | -113.41M |
| Cash from Operations | 263.60M | 44.08M | 111.61M | 138.83M | -95.59M |
| Capital Expenditure | -43.83M | -56.41M | -87.76M | -151.68M | -109.95M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.78M | -65.53M | -159.55M | 159.14M | -1.08M |
| Cash from Investing | -66.61M | -121.94M | -247.32M | 7.46M | -111.03M |
| Total Debt Issued | 141.52M | 80.00M | 548.58M | 60.48M | 182.38M |
| Total Debt Repaid | -115.45M | -177.14M | -558.78M | -63.09M | -167.93M |
| Issuance of Common Stock | 33.14M | 63.36M | 3.85M | 160.29M | 5.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -14.49M | -- |
| Other Financing Activities | -24.20M | -- | 22.20M | -161.18M | 3.00M |
| Cash from Financing | 35.03M | -33.78M | 30.05M | -14.98M | 23.02M |
| Foreign Exchange rate Adjustments | 23.48M | 3.48M | -49.99M | 26.02M | -5.90M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 255.50M | -108.16M | -155.64M | 157.33M | -189.51M |